HDAC6 and neoplasm: HDAC6 inhibitors can inhibit the function of tumor-associated macrophages and myeloid-derived suppressor cells in the tumor microenvironment, and promote the activity of cytotoxic T cells and memory T cells and their killing effect on tumor cells [59].